Molecule Name |
DB07751
|
DrugBank Groups |
Experimental
|
Cluster No |
1748
|
Smiles |
FC3(=C(NC1(=NC=NC(=C1)NC2(=CC=C(OCC(O)CN(C)C)C=C2)))C(F)=CC=C3)
|
Download |
mol2, pdbqt
|
TPSA |
317,11
|
Non-H Atoms |
30
|
Non-C/H Atoms |
9
|
Metal-Atoms |
0
|
Electronegative Atoms |
9
|
Stereo Centers |
1
|
Rotatable Bonds |
9
|
Rings Closures |
3
|
Small Rings |
3
|
Aromatic Rings |
3
|
Aromatic Atoms |
18
|
sp3-Atoms |
8
|
Symmetric atoms |
6
|
cLogS |
-4,758
|
MW |
415,443
|
cLogP |
3,124
|
HBA |
7
|
HBD |
3
|
Ro5 violations |
0
|
Druglikeness |
2,576
|
DrugScore |
0,609080264178482
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB+
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2+
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,0427
|
Caco-2 Permeability 2 |
0,9998
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,5074
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,5122
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,4006
|
Carcinogenicity (Three-class) |
Non-required
|